Skip to Main Content

Paper Details

Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial.
J Immunother Cancer
134
2020
PD-L1, Patients, Pembrolizumab, liver lesions, mNSCLC, metastatic non-small cell lung cancer, patients, pembrolizumab, programmed death-ligand 1
Author NameAffiliation
Kenneth R HessMD Anderson Cancer Center
Kenneth R HessMD Anderson Cancer Center
Steven H LinUniversity of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2